Share

Updates matching "National"

April 11, 2022
National

Washington, D.C.--Today ACS CAN filed comments with the Centers for Disease Control and Prevention regarding proposed clinical practice guidelines for prescribing opioids. Read the full comments

April 4, 2022
National

National Cancer Institute (NCI) director, Dr. Ned Sharpless, has announced he intends to leave his post at NCI at the end of April. Dr. Sharpless has led the Institute for five years during which time he proved to be a tireless advocate for increased investment in cancer research.

March 29, 2022
National

WASHINGTON, D.C.— Monday the Biden administration released its FY 2023 budget, which includes $5 billion for the forthcoming creation of the Advanced Research Project on Health (ARPA-H) but reduces funding by nearly $200 million for the National Cancer Institute (NCI); a scenario which may threaten to undermine the president’s

March 22, 2022
National

This Wednesday will mark 12 years since the Affordable Care Act was signed into law and cancer patients, survivors and millions of others gained expanded access to comprehensive health coverage.

March 22, 2022
National

This Wednesday will mark 12 years since the Affordable Care Act was signed into law and cancer patients, survivors and millions of others gained expanded access to comprehensive health coverage.

March 17, 2022
National

Tobacco use rates among US adults hit an all-time low, but rates remain high among certain populations according to data released by the Centers for Disease Control and Prevention today.

March 17, 2022
National

The cost of cancer care is substantially impacting the lives of cancer patients and survivors, forcing them to make significant lifestyle changes, and causing some to incur long-term medical debt.

March 10, 2022
National

A new survey released today from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) finds youth tobacco use remains a serious public health threat.

March 9, 2022
National

Tonight the House is considering a long-overdue FY2022 funding bill that addresses critical aspects of cancer research, prevention and access to care.